Blaize Holdings' shares dropped about 45% after it reported Q2 revenue below expectations and cut its full-year 2026 revenue forecast drastically from $130 million to $40-43 million, citing slower order conversion and higher memory costs. The company also faces a $7.1 million write-off and a securities class action, raising concerns about its speculative nature. Meanwhile, optics companies nLIGHT and Lightwave Logic showed resilience, with nLIGHT recovering slightly after a supply chain delay impacted its Q3 guidance, and Lightwave Logic benefiting from a broader optics rally despite ongoing losses. These developments highlight the contrasting fortunes in the photonics and AI hardware sectors.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...
